AdaptHealth (AHCO) Common Equity (2017 - 2026)

AdaptHealth's Common Equity history runs 10 years deep, the most recent figure standing at $1.5 billion for Q1 2026.

• On a quarterly basis, Common Equity fell 4.24% year-over-year to $1.5 billion in Q1 2026; TTM through Mar 2026 was $1.5 billion, a 4.24% decrease from a year earlier, with the FY2025 full-year figure at $1.5 billion, down 3.28% from the prior year.
• Common Equity eased to $1.5 billion in Q1 2026 per AHCO's latest filing, from $1.5 billion in the prior quarter.
• Across five years, Common Equity topped out at $2.2 billion in Q2 2023 and bottomed at $1.5 billion in Q4 2023.
• The 5-year median for Common Equity is $1.6 billion (2025), against an average of $1.8 billion.
• Across the five-year window, Common Equity advanced 18.31% in 2022 and tumbled 32.13% in 2024, its largest moves.
• Year by year, Common Equity stood at $2.2 billion in 2022, then sank by 32.03% to $1.5 billion in 2023, then climbed by 7.6% to $1.6 billion in 2024, then decreased by 3.28% to $1.5 billion in 2025, then retreated by 1.26% to $1.5 billion in 2026.
• Per Business Quant, the three latest AHCO Common Equity figures stand at $1.5 billion (Q1 2026), $1.5 billion (Q4 2025), and $1.6 billion (Q3 2025).